We're back 18-20 July 2022 UoOx - Transforming the communication of health evidence & risk for informing decisions - Developing & fostering future teachers & leaders in EBHC - Synthesizing & curating evidence & knowledge for better policy More details at ebmlive.org

Some musical gratitude for all the healthcare workers who do the impossible every day. Simple Gifts, #songsofcomfort

#MemeReg #MedTwitter #MRCP

📢Two of our students studying for the MSc in Evidence-Based Health Care have won the prestigious EBHC Dissertation Prize for their outstanding dissertations. Many congratulations to Drew Dagens & Stella Vieth!🌟🌟Details:👇 Centre for Evidence-Based Medicine cebm.ox.ac.uk/news/msc-ebhc-…

This was a great project. Looking forward to getting it published. Thanks to Annette Pluddemann and eduardo martinez for all their help! cebm.ox.ac.uk/news/msc-ebhc-…

Announcing the new Pandemic Sciences Institute youtu.be/m3CBATLy8wQ via YouTube

New RECOVERY result: Baricitinib 8156 patients randomly allocated to receive usual care plus baricitinib versus usual care alone. 28-day mortality lower in patients allocated baricitinib: 513/4148 (12%) vs 546/4008 (14%) (age-adjusted rate ratio 0.87; 95% CI 0.77-0.98; p=0.026)

An app that checked that (Figure 1) is in fact Figure 1 would change science for ever... #AcademicTwitter

Major boost for Oxford’s mission to counter future pandemic threats This extremely generous gift from the Moh Family Foundation launches the Pandemic Sciences Institute as a global asset to strengthen health security for all Pandemic Sciences Institute ox.ac.uk/news/2022-05-1…

NEW OpenSAFELY paper KLAXON Comparing sotrovimab and molnupiravir for prevention of severe outcomes in non-hospitalised patients with COVID-19. medrxiv.org/content/10.110… Preprint not yet peer reviewed, under review at a journal, sharing for info. INTERESTING THINGS THREAD: 1/n

Great article. A must-read for any military doc. theguardian.com/uk-news/2022/j…

In this trial, a restrictive approach to intravenous fluid administration in critically ill patients with septic shock did not reduce mortality. #CCR22 nej.md/39qGQ40

Fantastic opportunity for a dynamic & passionate individual to join Pandemic Sciences Institute. Nipah virus infection has a fatality rate of up to 75%. Come work with us to transform the way we prevent & treat this important high-threat infectious disease Peter Horby @peterhorby.bsky.social Jake Dunning Epidemic diseases Research Group Oxford

What's the fastest way to diagnose Ebola Virus Disease in low-resource settings? New paper in CMI #Ebola #EbolaOutbreakUG #EbolaOutbreak The Diagnostic Accuracy of Rapid Diagnostic Tests for Ebola Virus Disease: a Systematic Review clinicalmicrobiologyandinfection.com/article/S1198-…

Scandalous that so little is done about diseases like monkeypox until high income countries are affected. But there has been international cooperation to try to improve the situation: See BMJ article bmj.com/content/377/bm… Plus a clinical trial has started in DRC NCT05559099

Immortal time bias: a 🧵 When I was an infectious diseases intern, I attended Justin Denholm, Dr Street & Steven Tong's #VIDSJC journal club, we discussed this JAMA Internal Medicine paper: Association of Evidence-Based Care w Mortality in staph aureus bacteremia jamanetwork.com/journals/jamai…

Nice little article on the perils of publication bias economist.com/graphic-detail…

Ending Tuberculosis is within reach. So why are millions still dying? A brilliant article on the challenges (and opportunities) of ending TB and saving a hundred million lives over the next century. nytimes.com/2023/11/06/hea…

So, in the end, both France and Britain voted against the far-right. Doesn't mean the threat is gone, but pay attention to the center, center left, green and center right voters who are still the majority in Europe, everywhere except Hungary.

Influenza going up in the UK. For those involved in the RECOVERY trial of influenza treatments - please try to enrol patients. If this season is short and sharp, we will have a limited time window for recruitment.